Hou Y - Search Results

1

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Among authors: hou y. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

2

[Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].

Qiu LH, Wang HQ, Qian ZZ, Li W, Hou Y, Meng XR, Cui XZ, Hao XS. Qiu LH, et al. Among authors: hou y. Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):743-6. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646489 Chinese.

3

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

4

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

5

Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China.

Hou Y, Wang HQ, Ba Y. Hou Y, et al. Med Oncol. 2012 Dec;29(4):2372-8. doi: 10.1007/s12032-012-0184-1. Epub 2012 Mar 20. Med Oncol. 2012. PMID: 22430608

6

Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma.

Hou Y, Wang HQ, Ba Y. Hou Y, et al. Med Oncol. 2012 Dec;29(4):2409-16. doi: 10.1007/s12032-012-0211-2. Epub 2012 Apr 3. Med Oncol. 2012. PMID: 22476761

7

Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.

Wang HQ, Ren Y, Qian ZZ, Fu K, Zhang HL, Li W, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Among authors: hou y. Thorac Cancer. 2012 Feb;3(1):72-78. doi: 10.1111/j.1759-7714.2011.00083.x. Thorac Cancer. 2012. PMID: 28920255 Free article.

8

High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma.

Hou Y, Wang HQ, Ba Y. Hou Y, et al. Med Oncol. 2012 Dec;29(5):3498-503. doi: 10.1007/s12032-012-0223-y. Epub 2012 Apr 19. Med Oncol. 2012. PMID: 22528513

9

Effects of CDC7 gene silencing and Rituximab on apoptosis in diffuse large B cell lymphoma cells.

Hou Y, Wang HQ, Ba Y. Hou Y, et al. J Cancer Res Clin Oncol. 2012 Dec;138(12):2027-34. doi: 10.1007/s00432-012-1283-2. Epub 2012 Jul 18. J Cancer Res Clin Oncol. 2012. PMID: 22806309

10

Ethanol extracts of Cinnamomum migao H.W. Li attenuates neuroinflammation in cerebral ischemia-reperfusion injury via regulating TLR4-PI3K-Akt-NF-κB pathways.

Wu W, Xu L, Mu D, Wang D, Tan S, Liu L, Li Y, Chai H, Hou Y. Wu W, et al. Among authors: hou y. J Ethnopharmacol. 2024 Nov 21:119150. doi: 10.1016/j.jep.2024.119150. Online ahead of print. J Ethnopharmacol. 2024. PMID: 39580135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,366 results

Search Page

Filters